Rentokil Initial plc (RTO)
NYSE: RTO · Real-Time Price · USD
25.06
+1.21 (5.07%)
Aug 4, 2026, 4:00 PM EDT - Market closed
Rentokil Initial Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Rentokil Initial stock has a consensus rating of "Buy" and an average price target of $32.03. The average 1-year stock price forecast is 27.81% higher than the current stock price, while the lowest is $26.7 (+6.54%) and the highest is $35 (+39.66%).
Price Target: $32.03 (+27.81%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rentokil Initial stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 4, 2026 |
| Exane BNP Paribas | Exane BNP Paribas | Hold Downgrades $27 | Hold | Downgrades | $27 | +6.54% | Jul 31, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +39.66% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
7.23B
from 6.91B
Increased by 4.60%
Revenue Next Year
7.52B
from 7.23B
Increased by 4.14%
EPS This Year
0.28
from 0.26
Increased by 9.52%
EPS Next Year
0.31
from 0.28
Increased by 10.46%
EPS and Forward PE are based on non-GAAP adjusted numbers.